ストックスクリーナーアプリを入手
127.00
0.02%
-0.02
プレマーケット:
126.05
-0.95
-0.75%
Intra Cellular Therapies Inc (ITCI) 最新ニュース
Canaccord cuts Intra-Cellular stock rating, raises target to $132 - Investing.com
Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain - GlobeNewswire Inc.
R Squared Ltd Takes Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat
Moody Aldrich Partners LLC Sells 27,173 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat
SG Americas Securities LLC Purchases 8,673 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat
Why Intra-Cellular Therapies (ITCI) Is Skyrocketing Now - MSN
Merit Financial Group LLC Buys New Shares in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat
(ITCI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Why Intra-Cellular Therapies, Inc. (ITCI) Is Skyrocketing Now - MSN
StockNews.com Initiates Coverage on Intra-Cellular Therapies (NASDAQ:ITCI) - MarketBeat
Cantor Fitzgerald Estimates ITCI FY2025 Earnings - Defense World
Demystifying Intra-Cellular Therapies: Insights From 6 Analyst Reviews - Benzinga
J&J Says Deals Likely to Shrink After $14.6B Intra-Cellular Buy - BioSpace
Intra-Cellular Therapies (NASDAQ:ITCI) Given "Sector Perform" Rating at Royal Bank of Canada - MarketBeat
J&J’s Intra-Cellular deal could signal more mega-mergers for 2025 - Chemistry World
Barlow Wealth Partners Inc. Purchases Shares of 2,200 Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat
Johnson & Johnson acquires Intra-Cellular Therapies - Pf Media
Research Analysts Issue Forecasts for ITCI FY2025 Earnings - MarketBeat
RBC Capital cuts Intra-Cellular stock rating, hikes target to $132 - MSN
Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSEENFN), Intra-Cellular Therapies, Inc. (NasdaqITCI), H&E Equipment Services, Inc. (NasdaqHEES), Shutterstock, Inc. (NYSE - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LTRPA, OMIC, ITCI, CCNE on Behalf of Shareholders - Morningstar
Intra-Cellular Therapies Enters Merger Agreement with Johnson & Johnson - Defense World
Johnson & Johnson to acquire Intra-Cellular Therapies - Scientist Live
Avanza Fonder AB Buys New Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales - MSN
Why Intra-Cellular Therapies, Inc. (ITCI) Dominated Last Week’s Rally - MSN
Oak Ridge Investments LLC Boosts Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat
J&J to buy Intra-Cellular Therapies for $14.6 billion - MSN
Assenagon Asset Management S.A. Has $12.20 Million Stock Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat
Jim Cramer on Intra-Cellular Therapies, Inc. (ITCI): ‘Intra-Cellular Had Something’ - Insider Monkey
Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires - Insider Monkey
J&J to Acquire Intra-Cellular for About $14.6 Billion - MSN
Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer - MSN
Johnson & Johnson pays $14.6 billion for mental health biopharma company - DOTmed HealthCare Business News
Is Johnson & Johnson Stock Set to Reward Long-Term Holders? - Benzinga
Intra-Cellular Therapies acquisition will expand J&J’s presence in neurology space, says GlobalData - Express Pharma
Johnson & Johnson exploring takeover of Intra-CellularBloomberg - MSN
Intra-Cellular (ITCI) Surges 14.9%: Is This an Indication of Further Gains? - MSN
Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal - MSN
J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports - MSN
Why Intra-Cellular (ITCI) Led the Monday Upsurge? - MSN
These Stocks Are Moving the Most Today: Micron, Intra-Cellular Therapies, and More - MSN
J&J to acquire psychiatric drugs maker Intra-Cellular for $14.6 billion - MSN
Intra-Cellular Therapies (NASDAQ:ITCI) Raised to “Strong-Buy” at Cantor Fitzgerald - Defense World
0.79%
3.78%
大文字化:
|
ボリューム (24 時間):